Funding opportunities
753 live opportunities from Grants.gov, NIH, NSF, and more.
Public Health× remove
- It's interpersonal: Relationship quality, behavioral-social rhythms, and cardiovascular disease risk among middle-aged couplesNational Heart Lung and Blood InstitutePA-24-176 closes 4/30/2031up to $169,415activenih
- Clostridiodes difficile spore germination and therapeutic interventionNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 4/30/2031up to $769,354activenih
- The Metabolic Crossroads: Decoding Fentanyl's Impact on HIV/HBV Co-infection for Targeted InterventionsNational Institute on Drug AbusePAR-25-261 closes 4/30/2031up to $1,095,500activenih
- Improving Outcomes of Adolescents in Residential Substance use Treatment via a Technology-Assisted Parenting InterventionNational Institute on Drug AbusePAR-19-212 closes 4/30/2031up to $803,918activenih
- Genomic Epidemiology of Human Metapneumovirus in the United StatesNational Institute of Allergy and Infectious DiseasesPA-24-176 closes 4/30/2031up to $182,618activenih
- INNOVATE (Integrated National Network for Obstetric and Pediatric AdVAncement in Therapeutic Education)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-168 closes 4/30/2031up to $390,646activenih
- Psychosocial Stress in Early Life, Chronodisruption and Accelerated Aging in Mid Life: A Life-course ApproachNational Institute on AgingPA-25-301 closes 4/30/2031up to $646,620activenih
- Illuminating Neuropeptide Modulation of Substance Abuse Withdrawal: Novel Photochemical Tools for Precision ControlNational Institute on Drug AbuseRFA-DA-24-007 closes 4/30/2031up to $462,000activenih
- Examine the influence of product features in cannabis vape product marketingNational Institute on Drug AbusePA-25-305 closes 4/30/2031up to $632,694activenih
- A Genetics Approach to Candida albicans Gastrointestinal Colonization ResistanceNational Institute of Allergy and Infectious DiseasesPA-24-182 closes 4/30/2031up to $191,916activenih
- MicroRNAs in neural-derived extracellular vesicles as biomarkers in first episode schizophreniaNational Institute of Mental HealthPA-25-305 closes 3/31/2031up to $795,165activenih
- Early Life Stress, Cellular Vulnerability, and the Developmental Programming of Metabolic DiseaseNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 3/31/2031up to $776,971activenih
- Evaluating the impact of synthetic cooling agent cigarettes on smoking behavior and abuse liability: Implications for a menthol product standardNational Institute on Drug AbusePA-25-305 closes 3/31/2031up to $690,741activenih
- R-loop-induced CGG contraction as a therapeutic approach for Fragile X syndromeNational Institute of Mental HealthPA-25-301 closes 3/31/2031up to $824,998activenih
- Assessing Pathway-Specific Stroke Risks: A Multifaceted Approach Incorporating Generative AI, Environmental Exposures, and Population Characteristics.National Institute of Environmental Health SciencesPA-25-301 closes 3/31/2031up to $819,506activenih
- Biopsychosocial Intergenerational Risk and Resilience Factors in Pediatric Amplified Musculoskeletal PainNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 3/31/2031up to $756,375activenih
- Assessing the Risk of Fetal Fentanyl Syndrome Amid the Ongoing Fentanyl Epidemic: A Comprehensive Approach Using Diverse Data and MethodsNational Institute on Drug AbusePA-25-301 closes 3/31/2031up to $794,542activenih
- Family Assessment and Momentary Evaluation (FAME): Enhancing Self-Management in Youth with Spina BifidaEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-301 closes 3/31/2031up to $689,428activenih
- Long-acting nanoparticle antidotes for the treatment of synthetic opioid overdoseNational Institute on Drug AbusePA-20-185 closes 3/31/2031up to $723,125activenih
- Assessing the Role of Cannabis in Sober Living HousesNational Institute on Drug AbusePA-25-301 closes 3/31/2031up to $542,187activenih
- Investigating the cannabinoid receptor type 1 (CB1R) availability in individuals with opioid use disorder (OUD)National Institute on Drug AbusePA-25-303 closes 3/31/2031up to $659,834activenih
- MECHANISMS OF PROTEIN PHOSPHORYLATION AT THE AXON INITIAL SEGMENTNational Institute of Mental HealthPA-25-301 closes 3/31/2031up to $701,256activenih
- Population genomic screening in primary care practices serving an urban populationNational Human Genome Research InstituteRFA-HG-24-021 closes 3/31/2031up to $963,225activenih
- Immune Cell-Placenta-Serotonin Axis in Peripartum Depression and SSRI TherapyEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPAR-25-110 closes 3/31/2031up to $663,493activenih
- Multimodal Dynamics of Infant Attention: Eye, Brain, and Heart During Object PlayEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-301 closes 3/31/2031up to $332,140activenih